Satellos Bioscience

About:

ICo Therapeutics is focused on the research and development of drug delivery technologies.

Website: https://satellos.com/

Twitter/X: iCoThera

Top Investors: National Research Council of Canada Industrial Research Assistance Program

Description:

ICo Therapeutics is focused on the research and development of drug delivery technologies. By focusing efforts on development instead of research, iCo's business model aims to acquire the rights to drugs that are either off-patent, currently approved, or near commercialization and develop them by redosing or reformulating them for new or expanded labels. The subsequent development of these therapeutics may include drug delivery technologies-such as sustained-release or biodegradable matrices to extend patent coverage.

Total Funding Amount:

$8.58M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2005-01-01

Contact Email:

info(AT)icotherapeutics.com

Founders:

John Meekison

Number of Employees:

11-50

Last Funding Date:

2019-08-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai